Compare EVMN & VSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVMN | VSTS |
|---|---|---|
| Founded | 2020 | 1936 |
| Country | United States | United States |
| Employees | 48 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 914.1M | 1.0B |
| IPO Year | N/A | 2023 |
| Metric | EVMN | VSTS |
|---|---|---|
| Price | $24.11 | $9.59 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 10 | 4 |
| Target Price | ★ $43.88 | $5.88 |
| AVG Volume (30 Days) | 251.0K | ★ 975.8K |
| Earning Date | 06-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,734,839,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.67 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.89 | $3.98 |
| 52 Week High | $33.20 | $10.38 |
| Indicator | EVMN | VSTS |
|---|---|---|
| Relative Strength Index (RSI) | 44.62 | 62.93 |
| Support Level | $21.14 | $7.24 |
| Resistance Level | $25.50 | $9.80 |
| Average True Range (ATR) | 1.80 | 0.39 |
| MACD | -0.32 | -0.01 |
| Stochastic Oscillator | 13.16 | 58.42 |
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.